PharPoint Research, Inc.

Looking for the right CRO to support your upcoming clinical trial? PharPoint's CRO Selection Checklist highlights 38 criteria you should consider during a robust CRO selection process, covering: ✅ General information and capabilities ✅ Evaluating soft skills and culture fit ✅ Regulatory compliance ✅ Technology information Download the full checklist on our website:

What topics are most helpful to you in your early career? For those of you further in your career journey, what do you wish you knew early on? ⭐ Your feedback will help shape future editions of our CRO Career Insights newsletter.

Planning a trial within patients with type 2 diabetes (T2DM)? As you work to strategically overcome potential study challenges, consider: 👉 Patient-centricity: A successful T2DM study requires a focus on the patient's perspective. 👉 Managing compliance: Some T2DM studies may struggle with subject compliance. To mitigate this risk, consider strategies that leverage education and technology. 👉 Strategic site selection: For instance, ask yourself - are subjects more likely to visit specialist or primary physicians? To learn more about PharPoint's experience and how we can help you meet your upcoming study goals, reach out to our team.

A successful schizophrenia clinical trial requires things like: 👉 A thoughtful trial design, 👉 An understanding of patient traits, and 👉 Plans to overcome common challenges - like high drop out rates. Explore three strategies that can be implemented to help reduce high drop out rates in an upcoming schizophrenia trial. (Looking for study support from a client-focused contract research organization? Reach out to our team to learn more.)

According to a 2014 investigation into the scientific and regulatory reasons for delay and denial of FDA submissions, while some new drug applications fail because of inadequate drug performance, others fail to gain FDA approval because the information submitted is unsatisfactory. 🕒 Applications that required one or more resubmissions before approval had a median delay to approval of 435 days. Early interaction with a skilled biostatistics consultant and support from an experienced CRO team can help sponsors effectively navigate the submission process. Learn more about how PharPoint's team can help: https://lnkd.in/eKBW854P

Check out the latest edition of CRO Career Insights! In this issue, our Senior Recruiter, Cameron Bullman, highlights the critical role of continuous learning in career advancement and personal growth. Plus, explore exciting job opportunities at PharPoint and dive into must-read, career-related articles. #LifeAtPharPoint #LifeSciences #ClinicalResearch

Meet Meg! As Accounts Receivable Manager at PharPoint, she creates invoices, handles client communications, and processes payments. In this #MeetThePharPointTeam feature, Meg talks about her journey from graphic design to finance and how it’s never too late to make a career pivot. #LifeatPharPoint Read the full article: https://lnkd.in/e2jcDQ7a

Oncology trials are highly complex. What challenges should Sponsors conducting trials within blood cancers anticipate, and how does the team at PharPoint Research help clients tackle these challenges? Explore three common obstacles: 👇

Early team interaction lays the groundwork for a seamless handoff from clinical data management to biostatistics post-database lock. Clinical data management should engage a statistician in the following areas: 1️⃣ Review of electronic case report form (eCRF), ensuring design both minimizes site burden while providing everything needed for analysis 2️⃣ Review of data management plan 3️⃣ Review of planned edit checks 4️⃣ Review of coding dictionaries to ensure that statistical analysis plan (SAP) and database are aligned 5️⃣ Input on vendor data import agreements

September is Leukemia and Lymphoma Awareness Month. According to the Leukemia & Lymphoma Society, 1.6 million people are currently living with or in remission from blood cancers in the United States, with a new blood cancer diagnosis every 3 minutes. PharPoint is proud to support sponsors as they work to develop innovative treatment options, and has supported over 200+ trials within oncology since 2007. To learn more about how we can support an upcoming trial, visit our website.